We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGames Workshop Regulatory News (GAW)

Share Price Information for Games Workshop (GAW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,600.00
Bid: 9,600.00
Ask: 9,615.00
Change: 115.00 (1.21%)
Spread: 15.00 (0.156%)
Open: 9,645.00
High: 9,645.00
Low: 9,510.00
Prev. Close: 9,485.00
GAW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement to develop films and television series

18 Dec 2023 07:00

RNS Number : 1069X
Games Workshop Group PLC
18 December 2023
 

18 December 2023

Games Workshop Group PLC

("Games Workshop" or the "Company")

 

Agreement to develop films and television series

 

Further to its announcement on 16 December 2022, Games Workshop is pleased to announce that it has entered into an agreement with Amazon Content Services LLC, a subsidiary of Amazon.com, Inc., ("Amazon") for the prospective development by Amazon of Games Workshop's Warhammer 40,000 universe into films and television series, together with associated merchandising rights. 

 

Under the terms of the agreement, Games Workshop has granted exclusive rights to Amazon in relation to films and television series set within the Warhammer 40,000 universe, together with an option for Amazon to license equivalent rights in the Warhammer Fantasy universe following the release of the initial Warhammer 40,000 production. 

 

Games Workshop and Amazon will work together for a period of 12 months to agree creative guidelines for the films and television series to be developed by Amazon. The agreement will only proceed once the creative guidelines are mutually agreed between Games Workshop and Amazon.

 

A further announcement will be made in due course.

 

The Company makes no change to its forecast for the 53 week period ending 2 June 2024.

 

 

For further information, please contact:

 

Games Workshop Group PLC

 

 

Kevin Rountree, CEO

investorrelations@gwplc.com

Rachel Tongue, CFO

 

 

 

Investor relations website

http://investor.games-workshop.com

General website

www.warhammer.com

 

 

 

 

 

 

This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) no. 596/2014 (including as it forms part of the laws of England and Wales by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this announcement, such information will no longer constitute inside information. Ross Matthews, the Company's General Counsel and Company Secretary, is the person responsible for making the notification for the purposes of Article 17 of MAR.

 

This announcement contains certain forward-looking statements with respect to certain of the Company's current expectations and projections about future events including regarding the Company and its subsidiaries' (together the "Group") operations, performance and financial position. These statements reflect the directors' beliefs and expectations and involve a number of risks, uncertainties, assumptions and other factors which may occur in the future, are beyond the Group's control and could cause actual results, performance or achievements of the Group to differ materially from any expected future results, performance or achievements expressed or implied by such forward-looking statement(s).

 

The Group's principal risks were described in the Company's 2023 Annual Report which can be viewed

online, and any forward-looking statements should be construed in light of such risks, uncertainties

assumptions and other factors and the recipient should not place undue reliance on these forward-looking

statements as a prediction of actual results, performance or achievement. The information contained in this announcement is subject to change without notice and, except as required by applicable law, the Company does not assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained in it, nor do they intend to. The statements are made only as of the date of this announcement and no representation, assurance, guarantee or warranty is given in relation to them including as to their accuracy, completeness, or the basis on which they are made.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRGPGQUPUPWPPM
Date   Source Headline
22nd Apr 20247:00 amRNSDirector Shareholding
2nd Apr 20242:12 pmRNSTotal Voting Rights
21st Mar 20247:00 amRNSTrading Update and Dividend
1st Mar 20241:57 pmRNSBlock listing Interim Review
1st Mar 202411:31 amRNSTotal Voting Rights
27th Feb 20247:00 amRNSDirector Shareholding
1st Feb 20249:29 amRNSTotal Voting Rights
26th Jan 20244:00 pmRNSDirector Shareholding
24th Jan 20247:00 amRNSDirector Shareholding
9th Jan 20247:02 amRNSDividend
9th Jan 20247:00 amRNSHalf-yearly Report
2nd Jan 202412:16 pmRNSTotal Voting Rights
18th Dec 20239:00 amRNSDisclosure of New Directorship
18th Dec 20237:00 amRNSAgreement to develop films and television series
7th Dec 20237:00 amRNSHalf Year Trading Update
1st Dec 20232:08 pmRNSTotal Voting Rights
7th Nov 20233:09 pmRNSDirector Shareholding
1st Nov 20237:00 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSTotal Voting Rights
20th Sep 20232:32 pmRNS2023 AGM voting results
15th Sep 20237:00 amRNSTrading Update and Dividend
14th Sep 20237:00 amRNSHolding(s) in Company
13th Sep 20237:00 amRNSDirector Shareholding
1st Sep 20239:53 amRNSBlock listing Interim Review
1st Sep 20239:01 amRNSTotal Voting Rights
21st Aug 20232:37 pmRNSHolding(s) in Company
21st Aug 20238:51 amRNSHolding(s) in Company
4th Aug 20233:24 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSDirector Shareholding
1st Aug 20239:51 amRNSTotal Voting Rights
25th Jul 202312:42 pmRNSNotice of AGM and Related Party Transactions
25th Jul 20237:01 amRNSDividend
25th Jul 20237:00 amRNSAnnual Report
3rd Jul 20237:00 amRNSTotal Voting Rights
14th Jun 20237:00 amRNSYear End Trading Update
1st Jun 20237:00 amRNSTotal Voting Rights
22nd May 20231:02 pmRNSDirector Shareholding
18th May 20231:06 pmRNSDirectorate Change
17th May 20239:28 amRNSHolding(s) in Company
2nd May 20237:00 amRNSTotal Voting Rights
12th Apr 20237:00 amRNSDirectorate Changes
3rd Apr 20238:18 amRNSTotal Voting Rights
30th Mar 20233:11 pmRNSHolding(s) in Company
24th Mar 20232:40 pmRNSDirector Shareholding
24th Mar 202311:31 amRNSDividend Update
24th Mar 20237:00 amRNSTrading Update and Dividend
1st Mar 202312:24 pmRNSBlock listing Interim Review
1st Mar 202310:01 amRNSTotal Voting Rights
27th Feb 202311:50 amRNSDirector Shareholding
17th Feb 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.